These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 1669012

  • 1. [Effect of selected hypotensive drugs on the rate of sodium outflow through lymphocyte cell membranes and sodium lymphocyte levels in patients with primary hypertension].
    Halawa B, Mazurek W.
    Pol Tyg Lek; ; 46(1-3):35-8. PubMed ID: 1669012
    [Abstract] [Full Text] [Related]

  • 2. [Effect of normal and high sodium diet on the sodium outflow rate through lymphocyte cell membrane and lymphocyte sodium level in patients with mild primary hypertension].
    Halawa B, Mazurek W.
    Pol Tyg Lek; ; 46(1-3):25-7. PubMed ID: 1669011
    [Abstract] [Full Text] [Related]

  • 3. [Studies of lymphocyte membrane transport of sodium in patients with essential hypertension].
    Negrusz-Kawecka M.
    Pol Merkur Lekarski; 1999 Mar; 6(33):125-7. PubMed ID: 10365594
    [Abstract] [Full Text] [Related]

  • 4. [Sodium outflow rate through lymphocyte cellular membranes in women with arterial hypertension caused by pregnancy and in health pregnant women].
    Halawa B, Mazurek W, Robaczyński J.
    Pol Tyg Lek; 1999 Mar; 46(17-18):313-5. PubMed ID: 1669061
    [Abstract] [Full Text] [Related]

  • 5. Effect of treatment with hydrochlorothiazide on the red cell Na,K-adenosine triphosphatase in men with hypertension.
    Quintanilla AP, Finn M, Weffer MI, Del Greco F.
    J Lab Clin Med; 1987 Nov; 110(5):583-7. PubMed ID: 2822824
    [Abstract] [Full Text] [Related]

  • 6. Erythrocyte cation transport in obesity, hypertension, and during antihypertensive drug therapy.
    Miilunpalo S, Saarinen R, Marniemi J, Lehtonen A.
    Clin Physiol Biochem; 1989 Nov; 7(3-4):176-83. PubMed ID: 2572370
    [Abstract] [Full Text] [Related]

  • 7. [Rate of sodium ion outflow through the membranes of lymphocytes and its concentration in the lymphocytes of patients with hyper- and hypothyroidism].
    Halawa B.
    Pol Tyg Lek; 1989 Nov; 44(7-8):182-4. PubMed ID: 2554262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, Bianchi G.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [Abstract] [Full Text] [Related]

  • 10. [Effect of hypothiazide and reserpine on the intracellular and extracellular potassium and sodium correlation during the treatment of hypertensive disease].
    Gnedkova GL, Lazareva DN.
    Ter Arkh; 1971 Mar; 43(3):37-40. PubMed ID: 5561193
    [No Abstract] [Full Text] [Related]

  • 11. Lymphocyte cell membrane handling of sodium and blood pressure control during salt restriction in normotensive subjects.
    Jest P, Pedersen KE, Klitgaard NA, Arentoft A, Nielsen JR.
    J Hypertens Suppl; 1985 Dec; 3(3):S65-7. PubMed ID: 2856826
    [Abstract] [Full Text] [Related]

  • 12. Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension.
    Millar JA, Bramley PM, Paulin JM, Simpson FO.
    J Hypertens Suppl; 1984 Dec; 2(3):S461-3. PubMed ID: 6599699
    [Abstract] [Full Text] [Related]

  • 13. Modifications of intra- and extracellular sodium and potassium. A possible mechanism for the antihypertensive action of captopril and hydrochlorothiazide.
    Ambrosioni E, Costa FV, Borghi C, Mussi A, Boschi S.
    J Hypertens Suppl; 1985 Dec; 3(3):S69-71. PubMed ID: 2856785
    [Abstract] [Full Text] [Related]

  • 14. Cell membrane handling of sodium in lymphocytes during salt restriction in normotensives.
    Jest P, Pedersen KE, Klitgaard NA, Arentoft A, Nielsen JR.
    Scand J Clin Lab Invest; 1987 Dec; 47(8):813-8. PubMed ID: 3433003
    [Abstract] [Full Text] [Related]

  • 15. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.
    Ferrari P, Torielli L, Ferrandi M, Padoani G, Duzzi L, Florio M, Conti F, Melloni P, Vesci L, Corsico N, Bianchi G.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):83-94. PubMed ID: 9535997
    [Abstract] [Full Text] [Related]

  • 16. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M, Grichois ML, Pernollet MG, Thorman B, Meyer P, Devynck MA, Garay R.
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [Abstract] [Full Text] [Related]

  • 17. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
    Kedzierska K, Bober J, Ciechanowski K, Gołembiewska E, Kwiatkowska E, Noceń I, Dołegowska B, Dutkiewicz G, Chlubek D.
    Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of diuretic-induced hypopotassemia in human hypertension.
    Kezdi P, Danopulos D, Stanley EL, Mullins M.
    Klin Wochenschr; 1985 Oct; 63 Suppl 3():125-8. PubMed ID: 2987608
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P, Ferrandi M, Valentini G, Manunta P, Bianchi G.
    Med Hypotheses; 2007 Oct; 68(6):1307-14. PubMed ID: 17097240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.